Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 14.26% · OPTIONAL
· Pharmaceutical Preparations
RESEARCH SNAPSHOTALUMIS INC.'s latest supported as-filed period reports revenue of $1.7M, 37.7% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 14.26% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -4903.73% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -37.66% · CORE
Level · gp.fundamentals.operating_margin
Raw value -8956.38% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 5134.60% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 858.78% · OPTIONAL
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Free-cash-flow proxy changed +23.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash flow changed +23.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Each point keeps the date investors could first observe it and its accession.
ALMS · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001231919-26-001158SEC ↗8-KSep 1, 2026Period Sep 1, 20260001104659-26-104145SEC ↗10-QAug 13, 2026Period Jun 30, 20260001847367-26-000018SEC ↗8-KAug 13, 2026Period Aug 13, 20260001847367-26-000016SEC ↗8-KAug 10, 2026Period Aug 10, 20260001104659-26-093353SEC ↗4Aug 5, 2026Period Aug 3, 20260001744578-26-000005SEC ↗4Aug 5, 2026Period Aug 3, 20260002023806-26-000007SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 8, 2026Filed Sep 9, 2026 | AKKARAJU SRINIVASDirector | Open Market SaleIndirect | 48,066 | $11 | $507,019 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 9, 2026 | AKKARAJU SRINIVASDirector | Open Market SaleIndirect | 48,065 | $11 | $507,009 | Form 4 ↗ |
| Sep 8, 2026Filed Sep 9, 2026 | AKKARAJU SRINIVASDirector | Open Market PurchaseIndirect | 273,291 | $11 | $2.9M | Form 4 ↗ |
| Sep 8, 2026Filed Sep 9, 2026 | AKKARAJU SRINIVASDirector | Open Market PurchaseIndirect | 273,290 | $11 | $2.9M | Form 4 ↗ |
| Sep 4, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Operating margin changed -368485 basis points from the comparable as-filed period.
Revenue changed -37.7% from the comparable as-filed period.
Cash & equivalents changed -58.0% from the comparable as-filed period.
Research & development changed -21.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed -23.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001506218-26-000005| AKKARAJU SRINIVASDirector |
| Open Market PurchaseIndirect |
| 220,070 |
| $11 |
| $2.5M |
| Form 4 ↗ |
| Sep 4, 2026Filed Sep 9, 2026 | AKKARAJU SRINIVASDirector | Open Market PurchaseIndirect | 220,070 | $11 | $2.5M | Form 4 ↗ |
| Aug 3, 2026Filed Aug 5, 2026 | Schroer John R.Chief Financial Officer | Open Market SaleDirect | 3,282 | $26 | $86,546 | Form 4 ↗ |